Patent Application
20150376658
The disclosure generally relates to biological methods of making hydrocarbon feedstocks, in particular longer chain length organic acids and alcohols made in anaerobic microbes.
Four to ten carbon alkanes have many uses in our society, particularly as fuels and as feedstock for more complex chemicals. Most, however, are produced from petroleum, a dwindling reserve whose use creates significant ecological impact.
Butane (C4), for example, is mainly used for gasoline blending, as a fuel gas, either alone or in a mixture with propane, and as a feedstock for the manufacture of ethylene and butadiene, a key ingredient of synthetic rubber. Isobutane is primarily used by refineries to enhance the octane content of motor gasoline.
Very pure forms of butane, especially isobutane, can be used as refrigerants and have largely replaced the ozone layer-depleting halomethanes, for instance in household refrigerators and freezers. The system operating pressure for butane is lower than for the halomethanes, such as R-12, so R-12 systems such as in automotive air conditioning systems, when converted to butane will not function optimally.
Butane is also used as lighter fuel for a common lighter or butane torch and is sold bottled as a fuel for cooking and camping, and cordless hair irons are usually powered by butane cartridges.
In industry, hexanes (C6) are used in the formulation of glues for shoes, leather products, and roofing. They are also used to extract cooking oils from seeds, for cleansing and degreasing a variety of items, and in textile manufacturing. A typical laboratory use of hexanes is to extract oil and grease contaminants from water and soil for analysis. Since hexane cannot be easily deprotonated, it is used in the laboratory for reactions that involve very strong bases, such as the preparation of organolithiums, e.g. butyllithiums are typically supplied as a hexane solution. In many applications (especially pharmaceutical), the use of n-hexane is being phased out due to its long term toxicity, and often replaced by n-heptane, which will not form the toxic metabolite hexane-2,5-dione.
Octanes (C8) became well known in American popular culture in the mid- and late-sixties, when gasoline companies boasted of “high octane” levels in their gasoline advertisements. Thus, it too is useful in fuels. Decane (C10) undergoes combustion reactions in a similar fashion to other alkanes.
Thus, we can see that there are many important uses for low carbon number alkanes and the demand for C4+ alkanes is not expected to diminish any time soon. Yet as products of petroleum refining, the production of such alkanes contributes significantly to environmental degradation, and as our hydrocarbon resources continue to dwindle in availability, the alkanes can only be expected to increase in price over the long term.
There is also need for alcohols and acids of the C-4+ class such as butyrate, hexanoic acid, etc. and the corresponding alcohols that are used in many chemical processes. Chemical processes are known for interconversions among the C-4+ series of carbon compounds and used by the petrochemical industry, so a source of a particular reduced C-4+ compound can be useful for a variety of potential industrial processes.
Thus, what are needed in the art are biological sources for these important alkanes, and microbial production is being investigated in that regard. Unfortunately, not many bacteria make butane or hexane, at least not in significant amounts, and some of the bacteria that do are obligate anaerobes, which are difficult and expensive to culture.
Professor David Mullin, and his team have discovered a new bacteria, called Tu-103, a butane-producing bacteria that lives on glycerol—a byproduct of biodiesel synthesis, or on cellulose—a waste product in abundant supply from e.g., old newspapers. The microbe is unique because it can do this in the presence of oxygen, unlike some other types of bacterium, which means less expensive production techniques would be required than for most obligate anaerobes. However, little is known about this bacteria because details are being kept as a trade secret, and future patents may also prevent its use.
Nonetheless, the existence of such organisms has generated renewed interest in solventogenic bacteria, such as Clostridia, because it is anticipated that additional strains will be discovered that have some degree of tolerance to oxygen, removing some of the difficulties in using these organisms for the bioproduction of desired chemicals. Alternatively, increasing exposure to oxygen may induce some degree of oxygen tolerance, and/or random mutagenesis could result in such changes.
Clostridium acetobutylicum, for example, is an anaerobic, spore-forming prokaryote that produces the solvents butanol, acetone, and ethanol. The desired product of the C. acetobutylicum fermentation is butanol, which has superior fuel characteristics to ethanol, such as higher energy content and lower water miscibility. The C. acetobutylicum genome has been completely sequenced and annotated, and methods for genetic deletions and gene overexpression have been developed, making it even more attractive organism for further strain development. Clostridia can also grow on a variety of substrates, from simple pentoses and hexoses to complex polysaccharides.
The metabolism of C. acetobutylicum is typically biphasic in batch culture—the cells first produce acetate and butyrate, and later—butanol, acetone, and ethanol. During growth, the production of acids lowers the pH of the culture, which combined with butyrate accumulation causes a shift in metabolism towards solvent production.
As solvents are produced, the acids are typically re-assimilated and converted into solvents. With initiation of solvent formation, the cells commit to their sporulation program. In continuous culture or upon consecutive vegetative transfers, cells may degenerate whereby they become asporogenic and lose the capability to produce solvents. In this organism, the degeneration process is due to the loss of the pSOL1 megaplasmid, which carries the key solvent formation genes in the so-called sol locus made up of the sol operon (aad-ctfA-ctfB) (coding for the enzymes AAD and CoAT) and the adc gene (coding for the enzyme AADC,
What are needed in the art are additional methods of making C4-10 compounds using microbes. A method using some of the advantages of solventogenic bacteria, such as Clostridia may be of benefit as well.
The present invention describes a method to capture redox by heterologous expression of ferredoxin NAD(P) reductase to allow the formation of longer chain organic acids and alcohols in anaerobic microbes.
To demonstrate proof of concept, we used ABE (acetone:butanol:ethanol) producing Clostridium acetobutylicum ATCC824, as well as a mutant variant strain M5 that has lost the mega plasmid pSOL1 (Clark et al. 1989) and a mutant variant strain PJC4BK, that is disrupted in buk, the gene encoding the major butyrate kinase.
As noted above, C. acetobutylicum displays two phase metabolism tightly associated with different growth stages. During the exponential growth, cells mainly produce acetic acid, butyric acid, H2, ATP and NAD(P)H. In response to the acidic pH, the metabolism switches to solventogenesis wherein acids are re-consumed and acetone, butanol and ethanol produced to regenerate reducing equivalents.
A key enzyme of the C. acetobutylicum central metabolism is the pyruvate ferredoxin oxidoreductase (pfor,
To capture the lost redox via H2 production, we used ferredoxin-NAD(P)+ reductase (FNR) (EC 1.18.1.3, 1.18.1.2) from the green sulphur bacterium Chlorobium tepidum TLS which is capable of efficiently catalyzing reduction of both NADP+ and NAD+, NAD+ being the more favorable, in the presence of reduced ferredoxin (Fdred).
where Fdred=reduced ferredoxin and Fdox=oxidized ferredoxin
The 360 amino acid FNR protein encoding gene of Chlorobium tepidum was synthesized with a ribosome binding site (
This results in increase in NADH availability in vivo that is then channeled towards acetyl-CoA condensation and reduction to favor the formation of longer chain organic acids (such as butyric acid) and alcohols (such as butanol). The functionality of the newly introduced redox capturing ferredoxin enzyme was successfully demonstrated in anaerobic tube experiments performed in an anaerobic chamber. This increase in NADH availability significantly changed the final metabolite concentration pattern under anaerobic conditions.
We observed a change in metabolite pattern towards more butanol and less acetone in cultures of wild type Clostridia ATCC824, and more butyrate and less acetate in cultures of ATCC824 and M5 cells expressing FNR. The effect on the butyrate to acetate ratio was noticeable in ATCC824 cultures. During acidogenic stage (6 hr), the butyrate:acetate ratio was ˜0.7-1.1 in wild type vector control (ATCC824(pJIR750)) cultures; whereas, the butyrate:acetate ratio was ˜1.6 for FNR+ (ATCC824(pJIR750-FNR)) cultures (Table 1).
Significant change was observed in the pattern of butanol and acetone in the cultures of ATCC824. In wild type ATCC824 cells grown to solvent stage, we observed an increase in the ratio of butanol:acetone from 1.46 in the parental strain with vector, ATCC824(pJIR750), to 2.8 in the culture of cells bearing the FNR+ plasmid pJIR750-FNR (Table 2). The pattern of acetone and butyrate changed significantly in the cultures of ATCC824(pJIR750-FNR). We also observed that in the solvent production stage of ATCC824(pJIR750-FNR) at 48 hr, levels of acetone decreased and butyrate increased as compared to wild type vector control cells ATCC824(pJIR750).
The effect on the ratio of butyrate to acetate was considerable in M5 (Table 3). After 6 hr, the typical butyrate:acetate ratio of ˜1.14 was observed in control cultures of host M5 and M5(pJIR750) but in the strain M5(pJIR750-FNR) expressing the ferredoxin NAD(P) reductase the ratio was ˜2.8, and after 24 hr culture the ratios were 1.85 in the M5 cultures and 3.7 in the M5 FNR+ cultures (Table 3). These results indicate the added enzyme can divert redox to NADH and generate a more reduced pattern of metabolites, such as butyrate and butanol.
In the buk− mutant strain expressing pJIR750 or pJIR750-FNR, the levels of acetone, ethanol, acetate and butyrate were significantly different. In cultures of buk− fnr+ at 48 hr, the levels of acetone, acetate, butyrate and ethanol dropped to about 33%, 50%, 50% and 11%, respectively. The buk− (pJIR750-FNR) strain showed about 6% increase in butanol concentration at 48 hr as compared to buk− (pJIR750) vector alone strain. These changes were more significant in terms of butanol:acetone, total solvent/acid ratios and percent butanol of total solvents on gram basis.
The butanol:acetone ratio for buk− (pJIR750) were 1.5 and 2 as compared to 2.2 and 3.2 for buk− (pJIR750-FNR) at 24 and 48 hr, respectively. The solvent:acid ratio for buk− (pJIR750) were 8.4 and 7.8 as compared to 11.7 and 13.9 for buk− (pJIR750-FNR) at 24 and 48 hr, respectively. The percent butanol of total solvents on gram basis for buk− (pJIR750) was 56 and 60 as compared to 63 and 68 for buk− (pJIR750-FNR) at 24 and 48 hr, respectively.
In summary, the advantages and features of using an overexpressed ferredoxin-NAD(P) oxidoreductase include:
1. Capturing of redox which is otherwise used in the production of hydrogen and thereby increased availability of NADH.
2. Increased NADH levels in vivo results in formation of NADH dependent metabolites such as longer chain organic acid butyrate over acetate and butanol over acetone.
3. Enhanced yield of butyrate.
The experiments herein show that the proportion of butanol and butyarate is increased in the presence of the FNR gene encoded by C. tepidium. There are also FNR genes from plants and cyanobacteria and Plasmonium falciparum ferredoxin-NADP+ reductase that could be used in the invention. Most of those show a high preference for NADPH. Additionally, quite a bit of work has been done on the Anabaena enzyme, and it is also a useful enzymes for use hereunder.
One way to find other enzymes that can be used in the invention is by BLAST search of amino acid homologs:
Chlorobium tepidum
Chlorobium phaeobacteroides
Pelodictyon phaeoclathratiforme
Chlorobium ferrooxidans
Chlorobium chlorochromatii
Chlorobium limicola
Prosthecochloris vibrioformis
Pelodictyon luteolum
Prosthecochloris aestuari
Other FNR enzymes that might be used herein include those listed below, but typically several hundred are provided at e.g., UniProt or Brenda and other databases by protein name, gene name, by homology or by EC number.
Alcanivorax borkumensis
Arabidopsis thaliana
Bacillus subtilis
Chlamydomonas reinhardtii
Cryptosporidium parvum
Escherichia coli
Nostoc sp. ATCC 29151
Pisum sativum
Pseudomonas putida
Rhodobacter capsulatus
Synechococcus elongatus
Triticum aestivum
Synechocystis sp.
Sulfolobus tokodaii
Zea mays
Xanthomonas axonopodis
Chlamydomonas reinhardtii
Anabaena variabilis
Anabaena cylindrica
Nostoc sp. PCC 7120
Clostridium ljungdahlii
Halorhabdus tiamatea
Sphingomonas sp.
Pseudonocardia
dioxanivorans
Pseudonocardia
dioxanivorans
Halorhabdus tiamatea
Streptomyces griseus
Pseudomonas
resinovorans
Each of Initial cloning experiments sometimes proceed in E. coli for convenience since most of the required genes are already available in plasmids suitable for expression in E. coli, but the addition of genes to bacteria is of nearly universal applicability, so it will be possible to use a wide variety of organisms with the selection of suitable vectors for same. Furthermore, a number of databases include vector information and/or a repository of vectors. See e.g., Addgene.org which provides both a repository and a searchable database allowing vectors to be easily located and obtained from colleagues. See also Plasmid Information Database (PlasmID) and DNASU having over 191,000 plasmids. A collection of cloning vectors of E. coli is also kept at the National Institute of Genetics as a resource for the biological research community. Furthermore, vectors (including particular ORFS therein) are usually available from colleagues.
The enzymes can be added to the genome or on expression vectors, as desired. Preferably, multiple enzymes are expressed in one vector or multiple enzymes can be combined into one operon by adding the needed signals between coding regions. Further improvements can be had by overexpressing one or more, or even all of the enzymes, e.g., by adding extra copies to the cell via plasmid or other vector. Initial experiments will employ expression plasmids hosting 3 or more ORFs for convenience, but it may be preferred to insert operons or individual genes into the genome for stability reasons.
Still further improvements in yield can be had be removing competing pathways, such as those pathways for making e.g., acetate, and it is already well known in the art how to reduce or knockout these pathways. Our own lab has several patent applications addressing such improvements, and such hosts may also make suitable starting materials since they are already available.
Generally speaking, we have referenced protein names herein and included EC numbers for accurate identification, but it is understood that a change in protein activity can of course be effected by changing the gene. This provides clarity since the gene nomenclature can be widely divergent in bacteria, but the proteins are defined by their activities and EC numbers.
Once an exemplary protein is obtained, e.g., in E. coli, which is completely sequenced and which is the workhorse of genetic engineering and bioproduction, many additional examples proteins of similar activity can be identified by BLAST search or database search. Further, every protein record is linked to a gene record, making it easy to design overexpression vectors. Many of the needed enzymes are already available in vectors, and can often be obtained from cell depositories or from the researchers who cloned them. But, if necessary, new clones can be prepared based on available sequence information using RT-PCR techniques. Thus, it should be easily possible to obtain all of the needed enzymes for overexpression, and in fact, we already have several clones, and are collecting the rest.
Understanding the inherent degeneracy of the genetic code allows one of ordinary skill in the art to design multiple nucleotides that encode the same amino acid sequence. NCBI™ provides codon usage databases for optimizing DNA sequences for protein expression in various species. Using such databases, a gene or cDNA may be “optimized” for expression in E. coli or Clostridia or other bacterial species using the codon bias for the species in which the gene will be expressed.
In calculating “% identity” the unaligned terminal portions of the query sequence are not included in the calculation. The identity is calculated over the entire length of the reference sequence, thus short local alignments with a query sequence are not relevant (e.g., % identity=number of aligned residues in the query sequence/length of reference sequence). Alignments are performed using BLAST homology alignment as described by Tatusova T A & Madden T L (1999) FEMS Microbiol. Lett. 174:247-250. The default parameters were used, except the filters were turned OFF. As of Jan. 1, 2001 the default parameters were as follows: BLASTN or BLASTP as appropriate; Matrix=none for BLASTN, BLOSUM62 for BLASTP; G Cost to open gap default=5 for nucleotides, 1 1 for proteins; E Cost to extend gap [Integer] default=2 for nucleotides, 1 for proteins; q Penalty for nucleotide mismatch [Integer] default=−3; r reward for nucleotide match [Integer] default=1; e expect value [Real] default=10; W word size [Integer] default=1 1 for nucleotides, 3 for proteins; y Dropoff (X) for blast extensions in bits (default if zero) default=20 for blastn, 7 for other programs; X dropoff value for gapped alignment (in bits) 30 for blastn, 15 for other programs; Z final X dropoff value for gapped alignment (in bits) 50 for blastn, 25 for other programs. This program is available online at NCBI™ (ncbi.nlm.nih.gov/BLAST/).
As used herein the specification, “a” or “an” may mean one or more. As used herein in the claim(s), when used in conjunction with the word “comprising”, the words “a” or “an” may mean one or more than one. As used herein “another” may mean at least a second or more.
The term “about” means the stated value plus or minus the margin of error of measurement or plus or minus 10% if no method of measurement is indicated.
The use of the term “or” in the claims is used to mean “and/or” unless explicitly indicated to refer to alternatives only or if the alternatives are mutually exclusive.
The terms “comprise”, “have”, “include” and “contain” (and their variants) are open-ended linking verbs and allow the addition of other elements when used in a claim.
As used herein, the expressions “cell”, “cell line” and “cell culture” are used interchangeably and all such designations include progeny. Thus, the words “cells” and similar designations include the primary subject cell and cultures derived therefrom without regard for the number of transfers. It is also understood that all progeny may not be precisely identical in DNA content, due to deliberate or inadvertent mutations that arise after genetic engineering is concluded. Mutant progeny that have the same function or biological activity as screened for in the originally transformed cell are included. Where distinct designations are intended, it will be clear from the context.
The terms “operably associated” or “operably linked,” as used herein, refer to functionally coupled nucleic acid sequences.
As used herein “recombinant” is relating to, derived from, or containing genetically “engineered” material. In other words, the genome was intentionally manipulated by the hand of man in some way.
“Reduced activity” or “inactivation” is defined herein to be at least a 75% reduction in protein activity, as compared with an appropriate control species. Preferably, at least 80, 85, 90, 95% reduction in activity is attained, and in the most preferred embodiment, the activity is eliminated (100%). Proteins can be inactivated with inhibitors, by mutation, or by suppression of expression or translation, and the like. A negative superscript, as in buk−, indicates reduced activity.
“Overexpression” or “overexpressed” is defined herein to be at least 150% of protein activity as compared with an appropriate control species. If the gene/protein of is not available in the host species, any expression is overexpression. Overexpression can be achieved by mutating the protein to produce a more active form or a form that is resistant to inhibition, by removing inhibitors, or adding activators, and the like. Overexpression can also be achieved by removing repressors, adding multiple copies of the gene to the cell, or upregulating the endogenous gene, and the like. An overexpressed protein can be represented by the + symbol, e.g., FNR+.
As used herein “100% anaerobic” refers to those conditions of zero oxygen such that obligate anaerobes can grow. Anaerobic by contrast, may allow some very low degree of oxygen, such that anaerobes with some degree of oxygen tolerance can grow. It is now known that obligately anaerobic bacteria such as acetogenic bacteria are stable to periods of aerobiosis. See Wagner (1996).
The terms “disruption” as used herein, refer to cell strains in which the native gene or promoter is mutated, deleted, interrupted, or down regulated in such a way as to decrease the activity of the protein at least 90% over the wild type un-disrupted protein. A gene or protein can be completely (100%) reduced by knockout or removal of the entire genomic DNA sequence. A knockout mutant can be represented by the A symbol.
Use of a frame shift mutation, early stop codon, point mutations of critical residues, or deletions or insertions, and the like, can completely inactivate (100%) gene product by completely preventing transcription and/or translation of active protein.
The following abbreviations, plasmids and strains are used herein:
C. perfringens pIP404 replication origin;
The disclosure relates to bacteria for making C4+ organic acids, alcohols or derivatives thereof, as well as to methods of making C4+ organic acids, alcohols or derivatives therefrom by culturing the engineered bacteria described herein with a source of carbon, forming C4+ organic acids, alcohols or derivatives, harvesting said C4+ products. The products can be used as is, or converted to other desirable compounds such as alkanes, alkenes, alcohols, esters, acids, amides, and the like.
Preferred compounds made herein include the saturated C4-C8 acids (or esters thereof):
Other preferred products include the alcohols, butanol, pentanol, hexanol, heptanol and octanol.
Preferably, the above bacteria also have reduced fermentation pathways leading to competing products, such as acetate, lactate, ethanol and/or formate. Many such mutants are already available in the art and can be used as host cells, or the vectors can be used to introduce same.
Acetogens are a useful starting host, as they may contain one or more of the required enzymes (e.g., certain bacteria contain an enzyme for reaction 6), and be suitable for making C4-8 or C4-10 products. Most acetogens use the “Wood-Ljungdahl” pathway. The Wood-Ljungdahl pathway is a set of biochemical reactions used by some bacteria and archaea. It is also known as the reductive acetyl-CoA pathway, and enables certain organisms to use hydrogen as an electron donor and carbon dioxide as an electron acceptor as well as a building block for biosynthesis. In this pathway carbon dioxide is reduced to carbon monoxide, which is then converted to acetyl coenzyme A. Two enzymes participate, CO Dehydrogenase and acetyl-CoA synthase. The former catalyzes the reduction of the CO2 and the latter combines the resulting CO with a methyl group to give acetyl-CoA. Unlike the Reverse Krebs cycle and the Calvin cycle, this process is not cyclic.
Many acetogens are thought to be strict anaerobes, thus it may be preferred to perform some of the needed engineering in a more easily grown bacteria, such as E. coli, or other commonly engineering microbe. However, acetogens are also present in aerated soils and colonize habitats with fluctuating redox conditions (e.g., the rhizosphere of sea grass), suggesting that less strict isolates are obtainable, as confirmed by Mullin's work. The use of anaerobes that are less strict may be preferred as maintaining 100% anaerobic conditions is difficult and costly.
Other acetogens include Clostridium autoethanogenum, Eurobacterium limosum, Clostridium carboxidivorans P7, Peptostreptococcus products, and Butyribacterium methylotrophicum, Clostridium ljungdahlii and Acetobacterium woodii.
Still other bacteria that could be useful hosts include Clostridium, Butyrobacterium, Moorella thermoacetica, Sporomusa, Thermacetogenium phaeum, Clostridium thermocellum, Acetogenium kivui, Acetobacterium woodii, Butyribacterium methylotrophicum, Clostridium ljungdahlii, Clostridium thermoautotrophicum, Clostridium tyrobutyricum, or Eubacterium limosum, or any other organism that uses ferredoxin as a major means of electron transfer factor.
In more detail, the invention includes one or more of the following embodiments in any combination thereof:
Experiments were performed in anaerobic glove box containing 85% N2, 10% H2 and 5% CO2 atmosphere. Glycerol stocks of C. acetobutylicum ATCC 824 and its mutant strain M5 (Clark 1989) harboring pSOS94-FNR (
Samples were collected at various time points to measure OD600 and metabolites. 1 mL sample was centrifuged at 12,000 rpm for 5 min at room temperature to remove cell debris and clear supernatant was acidified with 20 μL 50% H2SO4. Metabolites such as ethanol, acetone, acetic acid, butanol and butyric acid were measured by gas chromatography equipped with FID detector and PoraPak™ QS 80/100 glass column.
In the Tables below, ATCC824 is wild type Clostridium acetobutylicum. M5 is a pSOL1− mutant strain of the same bacterium. This mutant is used to show that the redistribution of redox from reduced Fd can generate longer chain acids in the metabolite profile of an acidogenic culture, and would be similar to the acidigenic metabolites produced by Clostridium tyrobutyricum or clostridium butyricum, as an example of the effect on a non-solvent producing clostridium species. The A and B refer to different isolates from the same transformation.
pJIR750 is a Clostridium perfringens-Escherichia coli shuttle vector derived from pJIR418 (ATCC 77387) permitting expression of antibiotic resistance (chloramphenicol resistance (catP)) in both hosts. pJIR750-FNR contains a codon optimized gene for FNR (SEQ ID NO. 2).
The following experiment was done in a mutant of Clostridium acetobutylicum—PJC4BK—that is disrupted in buk, the gene encoding the major butyrate kinase, and called BUK or buk− herein. This strain has higher butanol formation than the parent ATCC824 because it is limited for the pathway from butyryl-CoA to butyrate as described in Green (1996). It was used as a host for the same plasmids described above in order to show the effect in a higher solvent forming derivative of C. acetobutylicum that already produces a higher level of butanol than the wild type parent.
pJIR750-FNR has a SalI fragment of pSOS94-FNR subcloned into pJIR750. pSOS94-FNR contains codon optimized Ferredoxin NAD(P) reductase of Chlorobium tepidium (DNA2.0 construct). pSOS94 is another shuttle vector for Clostridia, but the FNR was moved because the pSOS vector and the chromosome of the high solvent producing mutant both carry the MLS drug resistance marker for erythromycin. Thus, the use of a shuttle vector with a different selectable marker was needed.
A single colony from transformation plate (2×YTG agar plate with Thiamphenicol 20 μg/ml) inoculated in 10 mL CGM+ medium containing Th20—18 h at 37° C. (CGM+ is a modified CGM recipe with 50 g/L glucose) 100 μl of preculture inoculated in 10 mL CGM+ in 15 ml tube+Th20—37° C. for 72 hours. 1 ml sample collected at 6 h, 24 h, 48 h and 72 h—centrifuged, acidified with 20 μL 50% H2SO4 and ran on GC for metabolites and the results shown in Tables 4-7.
The experimental is as described in the previous examples.
Table 4 shows the addition of the plasmid with the FNR+ does not drastically effect the growth or OD value. The control Buk−JIR750 is with a plasmid alone with no FNR gene in it. The test strain has FNR encoded by the same vector. A and B are two different isolates from the same transformation.
The metabolite analysis of the fermentation products of the cultures is seen in Table 5, where butanol production is considerably improved.
Looking at important ratios for high butanol production processes, the effect of the added enzyme is significant and positive, as seen in Tables 6-8.
The butanol mass proportion is shown in Table 9, and butanol/solvent in Table 10.
These experiments show that the proportion of butanol and butyrate is increased in the presence of the FNR gene encoded by C. tepidium.
Although one might predict that any enzyme that reduces NAD to NADH could be used herein, our experimental work shows this is not in fact so. TER uses NADH directly to reduce the crotonyl-CoA to butyryl-CoA and has been used in E. coli to make butanol. However, our results show that it will not function as intended herein.
A different TER was tested and also found to be non-functional, suggesting that the above result is generally applicable. The gene coding for the T. denticola enzyme (Acc. No. NP—971211.1) was synthesized, expression optimized by DNA2.0, cloned into the vector pJIR750 and transformed into C. acetobutylicum M5 (a non-solvent producing strain) so acetate vs butyrate can be examined. Table 11 shows a reduction of butyrate, rather than an improvement.
The TER experiments were another way of doing the NADH utilization as this enzyme reduced the crotonyl-CoA to butyryl-CoA with just NADH rather than the Clostridial enzyme that uses NADH and oxidized Fd and gives butyryl-CoA and reduced Fd and NAD in a more complex bifurcating reaction. It was synthesized and expressed in the same way as the FNR enzyme, but it had a lowering effect on the butyrate and butanol in the way it was expressed and tested. These negative results suggest that the minimum requirement for functionality hereunder is addition of extra ferredoxin NAD(P)H reductase activity. We did not test TER in the presence of FNR to see if the coupled system had a positive effect.
Each of the following citations is incorporated by reference herein in its entirety for all purposes:
This Application claims priority to 62/016,842, filed Jun. 25, 2014, and incorporated by reference herein in its entirety for all purposes.
This invention was made with government support under CBET-1033552 awarded by the NSF. The government has certain rights in the invention.
| Number | Date | Country | |
|---|---|---|---|
| 62016842 | Jun 2014 | US |
